Market Cap 330.27M
Revenue (ttm) 0.00
Net Income (ttm) -86.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 46,786
Avg Vol 207,244
Day's Range N/A - N/A
Shares Out 50.27M
Stochastic %K 48%
Beta 0.42
Analysts Strong Sell
Price Target $21.50

Company Profile

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 500 8864
Address:
80 Guest Street, 5th Floor, Boston, United States
ExitSTRATjoe77
ExitSTRATjoe77 Jun. 18 at 7:30 PM
0 · Reply
rando321456
rando321456 Jun. 18 at 8:01 AM
$CLSD $AURA It was a few weeks ago but when Aura's ceo was talking about pricing they referenced the approved drug for the choroidal melanoma that has spread, which goes for about 600k before the patient dies. Am I off my rocker thinking that between choroidal melanoma and mets that they will just be doing 5 billion dollars in revenue if the data pattern holds?
1 · Reply
JarvisFlow
JarvisFlow Jun. 2 at 6:57 PM
JMP Securities has updated their rating for Aura Biosciences ( $AURA ) to Market Outperform with a price target of 19.
0 · Reply
JarvisFlow
JarvisFlow May. 23 at 1:23 PM
JMP Securities has updated their rating for Aura Biosciences ( $AURA ) to Market Outperform with a price target of 19.
0 · Reply
AZOZ
AZOZ May. 21 at 12:03 PM
$PAPL $RLMD $PSQH $AURA Insider's love it right now!
0 · Reply
They_call_me_tater_salad
They_call_me_tater_salad May. 17 at 7:11 PM
$ACHV $AURA $CRBP I’ve selected the best prospects from a large group of companies I have watched for some time. Monday I’ll be allocating the +$500K from my INZY exit last Friday as follows: ACHV - 50% AURA - 30% CRBP - 20% 12-18 Month Target: Best case (positive BLA for ACHV + strong AURA data): combined value could exceed $1.4M Base case (ACHV approved, AURA mixed, CRBP drifts): ~$700K$1M range Worst case (AURA and CRBP disappoint, ACHV delayed or diluted): portfolio value could drop to $325K-$375K - Around a 27% chance. As always… This is simply what I am doing. It’s not advice or a recommendation. Always research thoroughly before making a personal financial or investment decision.
2 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine May. 16 at 8:10 PM
$AURA just secured $69.9M in fresh capital through a combo share/warrant offering. Cash runway now extends into H1 2027 - buying time to advance their ocular/bladder cancer pipeline. Smart move pricing warrants at $4.90 strike, but dilution risk remains a sword of Damocles. Street likes the runway extension. https://www.sec.gov/Archives/edgar/data/1501796/000119312525121677/d213451d8k.htm
1 · Reply
DonCorleone77
DonCorleone77 May. 15 at 10:39 AM
$AURA Aura Biosciences announces common stock, warrant offering, no amount given Aura Biosciences announced the launch of an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of its common stock and, to certain investors, pre-funded warrants to purchase shares of common stock and accompanying warrants to purchase shares of its common stock. All of the shares of common stock, pre-funded warrants and accompanying common stock warrants to be sold in the offering will be offered by Aura. Leerink Partners and Evercore ISI are acting as joint bookrunning managers for the offering. LifeSci Capital is also acting as a bookrunning manager in the offering. Citizens Capital Markets and Scotiabank are acting as co-managers for the offering.
1 · Reply
Armonica423
Armonica423 May. 10 at 5:40 PM
$AURA Big exposure for CYDY at 3 oncology conferences this coming week, do your dd research
0 · Reply
Sillyspuh
Sillyspuh May. 8 at 5:12 PM
$AURA Any news, or just oversold?
0 · Reply
Latest News on AURA
3 Small-Cap Stocks Ready to Deliver Significant Growth

Oct 15, 2024, 12:40 PM EDT - 9 months ago

3 Small-Cap Stocks Ready to Deliver Significant Growth

FBRT TZOO


Aura Biosciences: Highly Derisked Late-Stage Eye Cancer Company

Sep 17, 2024, 12:31 PM EDT - 10 months ago

Aura Biosciences: Highly Derisked Late-Stage Eye Cancer Company


Aura Biosciences Touts Promising Data From Eye Cancer Candidate

Sep 12, 2024, 11:40 AM EDT - 10 months ago

Aura Biosciences Touts Promising Data From Eye Cancer Candidate


ExitSTRATjoe77
ExitSTRATjoe77 Jun. 18 at 7:30 PM
0 · Reply
rando321456
rando321456 Jun. 18 at 8:01 AM
$CLSD $AURA It was a few weeks ago but when Aura's ceo was talking about pricing they referenced the approved drug for the choroidal melanoma that has spread, which goes for about 600k before the patient dies. Am I off my rocker thinking that between choroidal melanoma and mets that they will just be doing 5 billion dollars in revenue if the data pattern holds?
1 · Reply
JarvisFlow
JarvisFlow Jun. 2 at 6:57 PM
JMP Securities has updated their rating for Aura Biosciences ( $AURA ) to Market Outperform with a price target of 19.
0 · Reply
JarvisFlow
JarvisFlow May. 23 at 1:23 PM
JMP Securities has updated their rating for Aura Biosciences ( $AURA ) to Market Outperform with a price target of 19.
0 · Reply
AZOZ
AZOZ May. 21 at 12:03 PM
$PAPL $RLMD $PSQH $AURA Insider's love it right now!
0 · Reply
They_call_me_tater_salad
They_call_me_tater_salad May. 17 at 7:11 PM
$ACHV $AURA $CRBP I’ve selected the best prospects from a large group of companies I have watched for some time. Monday I’ll be allocating the +$500K from my INZY exit last Friday as follows: ACHV - 50% AURA - 30% CRBP - 20% 12-18 Month Target: Best case (positive BLA for ACHV + strong AURA data): combined value could exceed $1.4M Base case (ACHV approved, AURA mixed, CRBP drifts): ~$700K$1M range Worst case (AURA and CRBP disappoint, ACHV delayed or diluted): portfolio value could drop to $325K-$375K - Around a 27% chance. As always… This is simply what I am doing. It’s not advice or a recommendation. Always research thoroughly before making a personal financial or investment decision.
2 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine May. 16 at 8:10 PM
$AURA just secured $69.9M in fresh capital through a combo share/warrant offering. Cash runway now extends into H1 2027 - buying time to advance their ocular/bladder cancer pipeline. Smart move pricing warrants at $4.90 strike, but dilution risk remains a sword of Damocles. Street likes the runway extension. https://www.sec.gov/Archives/edgar/data/1501796/000119312525121677/d213451d8k.htm
1 · Reply
DonCorleone77
DonCorleone77 May. 15 at 10:39 AM
$AURA Aura Biosciences announces common stock, warrant offering, no amount given Aura Biosciences announced the launch of an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of its common stock and, to certain investors, pre-funded warrants to purchase shares of common stock and accompanying warrants to purchase shares of its common stock. All of the shares of common stock, pre-funded warrants and accompanying common stock warrants to be sold in the offering will be offered by Aura. Leerink Partners and Evercore ISI are acting as joint bookrunning managers for the offering. LifeSci Capital is also acting as a bookrunning manager in the offering. Citizens Capital Markets and Scotiabank are acting as co-managers for the offering.
1 · Reply
Armonica423
Armonica423 May. 10 at 5:40 PM
$AURA Big exposure for CYDY at 3 oncology conferences this coming week, do your dd research
0 · Reply
Sillyspuh
Sillyspuh May. 8 at 5:12 PM
$AURA Any news, or just oversold?
0 · Reply
justiceforb_85
justiceforb_85 Apr. 24 at 3:30 AM
$AURA great potential in choroidal melanoma. However, not sure why company working on bladder cancer therapy which is a crowded/competitive field.
1 · Reply
Lowlow1
Lowlow1 Apr. 1 at 6:17 PM
$AURA Agmh very good price to jump in at 0.042 has to get to a dollar soon if I post again mybad we are holding over here..
0 · Reply
The_Sophisticate
The_Sophisticate Mar. 31 at 4:03 AM
0 · Reply
The_Sophisticate
The_Sophisticate Mar. 29 at 4:54 PM
@MS_Tammy Hey Tammy, any thoughts on $AURA for Monday morning?
0 · Reply
spike55
spike55 Mar. 28 at 8:00 PM
$AURA Bought @ 6.20
0 · Reply
valueforme
valueforme Mar. 27 at 1:18 AM
$AURA lol, why -15% ?
1 · Reply
Fib7867
Fib7867 Mar. 26 at 9:15 PM
#myAURAanalysis $AURA
0 · Reply
JarvisFlow
JarvisFlow Mar. 26 at 1:10 PM
Citizens Capital Markets updates rating for Aura Biosciences ( $AURA ) to Market Outperform, target set at 21 → 19.
0 · Reply
jotu
jotu Mar. 25 at 12:26 PM
$AURA looks good https://www.stocktitan.net/news/AURA/aura-biosciences-reports-fourth-quarter-and-full-year-2024-financial-ssovbu42qfcm.html
0 · Reply
JarvisFlow
JarvisFlow Mar. 25 at 11:00 AM
HC Wainwright & Co. has adjusted their stance on Aura Biosciences ( $AURA ), setting the rating to Buy with a target price of 22 → 25.
0 · Reply
rando321456
rando321456 Mar. 25 at 3:33 AM
$CLSD $AURA Gibney's involved with Aura now too, abit interesting.
1 · Reply